![Paul Mann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Mann
Chief Executive Officer at
ASP ISOTOPES INC.
Net worth: 49 M $ as of 2026-01-30
Profile
Paul E.
Mann is the founder of ASP Isotopes, Inc., founded in 2021, serving as Executive Chairman & Chief Executive Officer.
Mr. Mann is the founder of Quantum Leap Energy LLC, founded in 2023, serving as Chairman.
Mr. Mann was also the founder of Varian Biopharma, Inc...
Current positions included Chairman at Healthtech Solutions, Inc. since 2021, Executive Chairman at Skyline Builders Group Holding Ltd. since 2026, and Independent Director at Illumination Acquisition Corp.
I.
Former positions include Chairman at Varian Biopharmaceuticals, Inc. from 2020 to 2023, Independent Non-Executive Director at Abeona Therapeutics, Inc. from 2020 to 2023, Chief Financial Officer at RegenETP, Inc. from 2018 to 2020, Executive Director at Morgan Stanley & Co. LLC in 2011, Research Analyst at UBS Ltd. (Broker) from 2011 to 2012, Research Analyst at UBS AG (Private Banking UK) from 2011 to 2012, Analyst at Althea Capital LLP from 2012 to 2013, Analyst at SFM UK Management LLP from 2013 to 2014, Analyst at Deutsche Bank AG (Broker UK) in 2007, Research Analyst at Morgan Stanley & Co. International Plc, Manager-Healthcare Portfolio at Highbridge Capital Management LLC, Analyst at Soros Fund Management LLC, Research Scientist at Procter & Gamble Co. Mr. Mann completed undergraduate and graduate degrees at the University of Cambridge.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-11-30 | 7,759,538 ( 6.2% ) | 49 M $ | 2026-01-30 |
Latest news about Paul Mann
Paul Mann active positions
| Companies | Position | Start |
|---|---|---|
| HYB HOLDING CORP. | Chairman | 2021-09-20 |
| ASP ISOTOPES INC. | Chief Executive Officer | 2026-01-18 |
Former positions of Paul Mann
| Companies | Position | End |
|---|---|---|
Varian Biopharmaceuticals, Inc.
 Varian Biopharmaceuticals, Inc. Develops novel therapeutics for the treatment of cancer | Chairman | 2022-12-31 |
| ABEONA THERAPEUTICS INC. | Director/Board Member | 2022-12-31 |
| REGENETP, INC. | Director of Finance/CFO | 2020-03-31 |
SFM UK Management LLP
 SFM UK Management LLP SFM UK is an active manager which invests based on analyzing global macroeconomic trends. The firm undertakes private investments in public equity and invests in currencies and index-linked derivatives. | Analyst-Equity | 2014-06-30 |
Althea Capital LLP
 Althea Capital LLP Investment ManagersFinance Provides investment advice | Analyst-Equity | 2013-03-27 |
Training of Paul Mann
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
16
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 16 |
|---|---|
Procter & Gamble Co.
 Procter & Gamble Co. Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | |
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Soros Fund Management LLC
 Soros Fund Management LLC Investment ManagersFinance SFM aims to protect and grow Open Society’s resources. The firm invests globally in a wide range of strategies and asset classes, including public equities, fixed income, commodities, foreign exchange, alternative assets and private equity. | Finance |
Highbridge Capital Management LLC
 Highbridge Capital Management LLC Investment ManagersFinance Highbridge seeks to generate attractive risk-adjusted returns by offering credit and volatility-focused solutions across a range of liquidity and investment profiles, including hedge funds, drawdown vehicles and co-investments. The firm opportunistically invests across the capital structure in less efficient segments of the market with the goal of generating consistent, alpha-driven returns across market cycles. | Finance |
Morgan Stanley & Co. LLC
 Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
RegenETP, Inc.
 RegenETP, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops and commercializes regenerative tissue products & biomaterials | Commercial Services |
UBS Ltd. (Broker)
 UBS Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deutsche Bank AG (Broker UK)
 Deutsche Bank AG (Broker UK) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Morgan Stanley & Co. International Plc
 Morgan Stanley & Co. International Plc Investment Banks/BrokersFinance Provides brokerage services | Finance |
Healthtech Solutions, Inc.
 Healthtech Solutions, Inc. Packaged SoftwareTechnology Services Operates as a holding company whose subsidiaries develops artificial intelligence based image analysis software, ultrasound imaging, diagnostic laboratory and human cell & tissue products | Technology Services |
Althea Capital LLP
Althea Capital LLP Investment ManagersFinance Provides investment advice | Finance |
SFM UK Management LLP
SFM UK Management LLP SFM UK is an active manager which invests based on analyzing global macroeconomic trends. The firm undertakes private investments in public equity and invests in currencies and index-linked derivatives. | |
UBS AG (Private Banking UK)
 UBS AG (Private Banking UK) UBS AG is an active manager which offers investment capabilities and styles across traditional and alternative asset classes. The firm provides clients with expert advice, innovative solutions, execution and comprehensive access to international capital markets. | |
Varian Biopharmaceuticals, Inc.
Varian Biopharmaceuticals, Inc. Develops novel therapeutics for the treatment of cancer | |
ASP Isotopes, Inc.
 ASP Isotopes, Inc. Operates as a pre-commercial stage materials company that produces, distributes, markets and sells isotopes |
- Stock Market
- Insiders
- Paul Mann
